-
Genesis MedTech Secures NMPA Approval for Innovative Surgical Energy Products
•
Genesis MedTech, a leading medical device company headquartered in Singapore, has secured marketing approvals from China’s National Medical Products Administration (NMPA) for two of its high-frequency electrosurgical energy products: the “OP9 ultrasonic high frequency integrated surgical equipment” and the “disposable cutting and closing knife head.” The OP9 device is a…
-
Genesis MedTech’s J-VALVE System Transfers to Edwards Lifesciences, Marking a New Era in Aortic Valve Treatment
•
SINGAPORE—In a strategic move to strengthen its position in the global medical device market, Edwards Lifesciences has announced the acquisition of intellectual property and commercial rights to Genesis MedTech’s J-VALVE transcatheter aortic valve system. This acquisition highlights Edwards Lifesciences’ commitment to advancing cardiovascular care and underscores its ongoing expansion strategy.…
-
Genesis MedTech Secures Hundreds of Millions in Funding to Boost R&D and Manufacturing in China
•
Singapore-based medical device company Genesis MedTech has raised “hundreds of millions” of renminbi in a recent financing round co-led by Wuxi Capital Group and Wuxi Binhu Industrial Investment and Development, alongside a prominent U.S. medical device firm. The funding will support product research and development at its Wuxi facility, as…
-
Genesis MedTech Receives Chinese Market Approval for Antibacterial Absorbable Sutures
•
Singapore-based medical device company Genesis MedTech has announced that it has received market approval in China for its absorbable sutures with antibacterial protection. This milestone marks the company as the first domestic brand to successfully develop such a product, enhancing its position in the medical device market. Innovation in Surgical…
